Rehydration and nutritional management

Beth Rivin, Mathuram Santosham

Research output: Contribution to journalArticle

Abstract

Diarrhoea remains a leading worldwide cause of morbidity and mortality. In developing countries alone, 1.5 billion episodes of diarrhoea occur per year in children under 5 years of age and approximately 4 000 000 of these result in death. Early, appropriate therapy decreases the risk of complications and death due to diarrhoea. Regardless of the causative agent, oral rehydration and nutritional management are the mainstays of good management of infants, children and adults with diarrhoea. Diarrhoeal disease control programmes throughout the developing world have adopted the WHO case management plan as a standard. In this chapter, we review the history, successes and shortcomings of various oral rehydration therapies and recommend a case management approach that is similar to the WHO plan. Although ORT is safe, effective, convenient and economical, this therapy has not been universally implemented in health care settings. The challenge for clinical and public health practitioners in developing and developed countries is to identify and overcome the barriers that exist so that all patients with diarrhoea will have the opportunity to receive optimal care.

Original languageEnglish (US)
Pages (from-to)451-476
Number of pages26
JournalBailliere's Clinical Gastroenterology
Volume7
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Fluid Therapy
Diarrhea
Case Management
Developing Countries
Secondary Prevention
Developed Countries
Public Health
History
Morbidity
Delivery of Health Care
Mortality

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Rehydration and nutritional management. / Rivin, Beth; Santosham, Mathuram.

In: Bailliere's Clinical Gastroenterology, Vol. 7, No. 2, 1993, p. 451-476.

Research output: Contribution to journalArticle

@article{0e36ac29be4e4a48b077f8e312fc803a,
title = "Rehydration and nutritional management",
abstract = "Diarrhoea remains a leading worldwide cause of morbidity and mortality. In developing countries alone, 1.5 billion episodes of diarrhoea occur per year in children under 5 years of age and approximately 4 000 000 of these result in death. Early, appropriate therapy decreases the risk of complications and death due to diarrhoea. Regardless of the causative agent, oral rehydration and nutritional management are the mainstays of good management of infants, children and adults with diarrhoea. Diarrhoeal disease control programmes throughout the developing world have adopted the WHO case management plan as a standard. In this chapter, we review the history, successes and shortcomings of various oral rehydration therapies and recommend a case management approach that is similar to the WHO plan. Although ORT is safe, effective, convenient and economical, this therapy has not been universally implemented in health care settings. The challenge for clinical and public health practitioners in developing and developed countries is to identify and overcome the barriers that exist so that all patients with diarrhoea will have the opportunity to receive optimal care.",
author = "Beth Rivin and Mathuram Santosham",
year = "1993",
doi = "10.1016/0950-3528(93)90049-X",
language = "English (US)",
volume = "7",
pages = "451--476",
journal = "Bailliere's Clinical Gastroenterology",
issn = "0950-3528",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - Rehydration and nutritional management

AU - Rivin, Beth

AU - Santosham, Mathuram

PY - 1993

Y1 - 1993

N2 - Diarrhoea remains a leading worldwide cause of morbidity and mortality. In developing countries alone, 1.5 billion episodes of diarrhoea occur per year in children under 5 years of age and approximately 4 000 000 of these result in death. Early, appropriate therapy decreases the risk of complications and death due to diarrhoea. Regardless of the causative agent, oral rehydration and nutritional management are the mainstays of good management of infants, children and adults with diarrhoea. Diarrhoeal disease control programmes throughout the developing world have adopted the WHO case management plan as a standard. In this chapter, we review the history, successes and shortcomings of various oral rehydration therapies and recommend a case management approach that is similar to the WHO plan. Although ORT is safe, effective, convenient and economical, this therapy has not been universally implemented in health care settings. The challenge for clinical and public health practitioners in developing and developed countries is to identify and overcome the barriers that exist so that all patients with diarrhoea will have the opportunity to receive optimal care.

AB - Diarrhoea remains a leading worldwide cause of morbidity and mortality. In developing countries alone, 1.5 billion episodes of diarrhoea occur per year in children under 5 years of age and approximately 4 000 000 of these result in death. Early, appropriate therapy decreases the risk of complications and death due to diarrhoea. Regardless of the causative agent, oral rehydration and nutritional management are the mainstays of good management of infants, children and adults with diarrhoea. Diarrhoeal disease control programmes throughout the developing world have adopted the WHO case management plan as a standard. In this chapter, we review the history, successes and shortcomings of various oral rehydration therapies and recommend a case management approach that is similar to the WHO plan. Although ORT is safe, effective, convenient and economical, this therapy has not been universally implemented in health care settings. The challenge for clinical and public health practitioners in developing and developed countries is to identify and overcome the barriers that exist so that all patients with diarrhoea will have the opportunity to receive optimal care.

UR - http://www.scopus.com/inward/record.url?scp=0027220155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027220155&partnerID=8YFLogxK

U2 - 10.1016/0950-3528(93)90049-X

DO - 10.1016/0950-3528(93)90049-X

M3 - Article

C2 - 8364250

AN - SCOPUS:0027220155

VL - 7

SP - 451

EP - 476

JO - Bailliere's Clinical Gastroenterology

JF - Bailliere's Clinical Gastroenterology

SN - 0950-3528

IS - 2

ER -